AAV Therapy Attenuates Respiratory Dysfunction in a Novel Rat Model of Pompe Disease

被引：0
|
作者：
Mahajan, Bhuvna [1 ]
Vaught, Lauren A. [1 ]
Todd, A. Gary [2 ]
Duncanson, Lauren A. [1 ]
Doyle, Brendan [3 ]
Fuller, David D. [3 ]
Byrne, Barry J. [1 ]
Falk, Darin J. [1 ]
机构：
[1] Univ Florida, Pediat, Gainesville, FL USA
[2] Univ Florida, Pharmacol & Therapeut, Gainesville, FL USA
[3] Univ Florida, Phys Therapy, Gainesville, FL USA
来源：
MOLECULAR THERAPY | 2018年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
356
引用
收藏
页码：166 / 166
页数：1
相关论文
共 50 条
  • [1] AAV Therapy Attenuates Respiratory Dysfunction and Glycogen Accumulation in a Murine Model of Glycogen Storage Disease Type II
    Falk, Darin J.
    Soustek, Meghan S.
    Todd, A. Gary
    Mah, Cathryn S.
    Cloutier, Denise A.
    Clement, Nathalie
    Fuller, David D.
    Byrne, Barry J.
    MOLECULAR THERAPY, 2015, 23 : S159 - S159
  • [2] AAV9 Attenuates Neuromuscular Pathology in Pompe Disease
    Todd, A. Gary
    McElroy, Jessica A.
    Grange, Robert W.
    Fuller, David D.
    Walter, Glenn A.
    Byrne, Barry J.
    Darin, Falk J.
    MOLECULAR THERAPY, 2014, 22 : S155 - S155
  • [3] Treatment of infantile-onset Pompe disease in a rat model with muscle-directed AAV gene therapy
    Munoz, Sergio
    Bertolin, Joan
    Jimenez, Veronica
    Jaen, Maria Luisa
    Garcia, Miquel
    Pujol, Anna
    Vila, Laia
    Sacristan, Victor
    Barbon, Elena
    Ronzitti, Giuseppe
    El Andari, Jihad
    Tulalamba, Warut
    Pham, Quang Hong
    Ruberte, Jesus
    VandenDriessche, Thierry
    Chuah, Marinee K.
    Grimm, Dirk
    Mingozzi, Federico
    Bosch, Fatima
    MOLECULAR METABOLISM, 2024, 81
  • [4] Treatment of Infantile-Onset Pompe Disease in a Rat Model with Muscle-Directed AAV Gene Therapy
    Garcia, Miquel
    Munoz, Sergio
    Bertolin, Joan
    Jimenez, Veronica
    Jaen, Maria Luisa
    Pujol, Anna
    Vila, Laia
    Sacristan, Victor
    Barbon, Elena
    Ronzitti, Giuseppe
    El Andari, Jihad
    Tulalamba, Warut
    Pham, Quang Hong
    Ruberte, Jesus
    Vandendriessche, Thierry C.
    Chuah, Marinee K. L.
    Grimm, Dirk
    Mingozzi, Federico
    Bosch, Fatima
    MOLECULAR THERAPY, 2023, 31 (04) : 785 - 785
  • [5] AAV-mediated gene therapy of Pompe disease
    Ziegler, RJ
    Bercury, S
    Armentaro, D
    Raben, N
    Cheng, SH
    NEUROMUSCULAR DISORDERS, 2005, 15 (9-10) : 713 - 713
  • [6] AAV-GAA Gene Therapy Clears Long Chain Length Neuronal Glycogen in a Pompe Disease Rat Model
    Fuller, David D.
    Rana, Sabhya
    Ribas, Roberto A.
    Shedlock, Cameron J.
    Larson, Reece
    PHYSIOLOGY, 2024, 39
  • [7] Reduction of Autophagic Accumulation in Pompe Disease Mouse Model Following AAV Gene Therapy
    McCall, Angela L.
    Stankov, Sylvia G.
    Falk, Darin J.
    Byrne, Barry
    MOLECULAR THERAPY, 2017, 25 (05) : 100 - 100
  • [8] Advancements in AAV-mediated Gene Therapy for Pompe Disease
    Salabarria, S. M.
    Nair, J.
    Clement, N.
    Smith, B. K.
    Raben, N.
    Fuller, D. D.
    Byrne, B. J.
    Corti, M.
    JOURNAL OF NEUROMUSCULAR DISEASES, 2020, 7 (01) : 15 - 31
  • [9] Neonatal gene therapy restores breathing in a rat model of Pompe disease
    Fuller, David
    Rana, Sabhya
    Pope, Megan
    Thakre, Prajwal
    Corti, Manuela
    Byrne, Barry
    PHYSIOLOGY, 2023, 38
  • [10] Tongue and Hypoglossal Motoneuron Gene Therapy in a Rat Model of Pompe Disease
    Singer, Michele
    Rana, Sabhya
    Pope, Megan
    Patterson, LiAna
    Corti, Manuela
    Byrne, Barry
    Fuller, David
    FASEB JOURNAL, 2021, 35
12345